Related Experiment Videos
[Neurological and electrophysiological disorders in children with bronchial asthma]
Zhurnal Nevropatologii I Psikhiatrii Imeni S.S. Korsakova (Moscow, Russia : 1952)
|January 1, 1988
Insights
Neurological and electrophysiological disorders are common in children with atopic bronchial asthma, particularly in younger children and those with longer-term asthma. Integrated care from pulmonologists and neuropathologists is recommended.
Area of Science:
- Pediatric Neurology
- Clinical Electrophysiology
- Respiratory Medicine
Context:
- Atopic bronchial asthma is a prevalent chronic respiratory condition in children.
- Post-attack periods in asthma can reveal underlying neurological and electrophysiological changes.
- Understanding these comorbidities is crucial for comprehensive pediatric care.
Purpose:
- To investigate neurological and electrophysiological disorders in children with atopic bronchial asthma.
- To identify factors influencing the prevalence of these disorders.
- To inform treatment strategies for affected children.
Summary:
- Fifty children aged 4-14 with atopic bronchial asthma were assessed for neurological and electrophysiological (REG, EEG, Echo-EG) disorders during the post-attack phase.
- Identified changes were more prevalent in 5-6-year-olds and in children with asthma duration of 3-4 years.
- Findings suggest a link between asthma chronicity, age, and neurological/electrophysiological alterations.
Impact:
- Highlights the need for neurological and electrophysiological monitoring in pediatric asthma patients.
- Suggests early intervention and integrated management involving pulmonologists and neuropathologists.
- Informs clinical practice regarding the comprehensive care of children with atopic bronchial asthma.
Abstract:
The authors have studied neurological and electrophysiological (REG, EEG, Echo-EG) disorders in 50 children (4-14 years) with atopic bronchial asthma in the post-attack period. The changes identified were more frequent in 5-6-year-olds and in cases where the disease persisted for 3-4 years. Multiple modality treatment should be preferably conducted under the observation of the pulmonologist and neuropathologist.